Solventum (SOLV) r&d spend was $739M in FY2025 (-5% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$739M
-5%
2024
$775M
+2%
2023
$758M
-1%
2022
$767M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$178M
Q1 2026
$189M
Q4 2025
$175M
Q3 2025
$183M
Q2 2025
$189M
Q1 2025
$193M
Q4 2024
$199M
Q3 2024
$189M
Q2 2024
$192M
Q1 2024
$195M
Q4 2023
$190M
Q3 2023
$180M
Source: SOLV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.